I now have comprehensive data from authoritative textbooks and literature. Let me compile the full, detailed response.
Pediatric Renal Masses: Comprehensive Imaging Guide
Overview of Pediatric Renal/Retroperitoneal Masses
Pediatric abdominal masses have a broad differential. The key solid masses encountered are:
| Tumor | Peak Age | Origin | Key Feature |
|---|
| Wilms tumor (nephroblastoma) | 2-5 years | Renal parenchyma | Most common childhood renal tumor |
| Neuroblastoma | < 2 years | Adrenal medulla / sympathetic chain | Most common extracranial solid tumor in childhood |
| Congenital mesoblastic nephroma | < 3 months | Renal stroma | Most common renal tumor in neonates |
| Clear cell sarcoma of kidney (CCSK) | 1-4 years | Renal | "Bone-metastasizing" tumor |
| Rhabdoid tumor of kidney (RTK) | < 2 years | Renal | Most aggressive; associated with brain tumors |
| Multilocular cystic nephroma | Bimodal (< 2 yr, 30-50 yr women) | Renal | Benign, cystic |
| Renal cell carcinoma | Adolescents | Renal cortex | Rare in children |
| Metanephric adenoma | Any age | Renal | Rare, benign |
PART I: WILMS TUMOR (NEPHROBLASTOMA)
Epidemiology & Clinical Features
- Most common solid renal tumor of childhood, ~5% of all childhood cancers
- ~650 new cases/year in the USA; peak age is 3rd year of life
- Equal sex distribution, equal kidney frequency; bilateral in 5% of cases
- Most present as an asymptomatic abdominal mass noticed by a parent; sometimes found on a well-child visit
- ~10-15% have metastatic disease at diagnosis; lungs (85-95%) and liver (10-15%) are most common sites
Pathophysiology
- Arises from metanephric blastema - pluripotent embryonal renal precursor cells
- Two-hit hypothesis (Knudson-Strong, 1972): sporadic form = 2 post-zygotic somatic mutations; familial form = 1 germline + 1 somatic mutation
- WT1 gene on chromosome 11p13 is implicated (though only 5-10% of sporadic tumors have WT1 mutations)
- Other genes: IGF1, H19, p57 (Beckwith-Wiedemann), WT2 on 11p15
- Nephrogenic rests (NRs): precursor lesions classified as:
- Perilobar NRs - located at the periphery of the renal lobe; associated with Beckwith-Wiedemann syndrome
- Intralobar NRs - within the renal lobe; associated with WAGR, Denys-Drash syndrome
Pathology (Histology)
- Classic triphasic composition: blastema + epithelial + stromal elements in varying proportions
- Favorable histology (FH): all tumors without anaplasia (~90%)
- Unfavorable histology (UH): anaplastic tumors (focal or diffuse), CCSK, rhabdoid tumors
- Anaplasia in 5%; more common in older children and African-Americans; linked to p53 mutations
- Diffuse anaplasia = worse prognosis than focal
- Grossly: large, multilobulated, gray-tan with hemorrhage and necrosis; fibrous pseudocapsule often present
Wilms tumor: classic triphasic pattern with tubular/glomeruloid structures and blastema (×40) - Smith and Tanagho's General Urology
Imaging of Wilms Tumor
Plain Radiography (X-ray / KUB)
- Large soft-tissue flank mass displacing bowel medially and contralaterally
- Calcifications uncommon - present in only ~10% (rim/curvilinear pattern; much less than neuroblastoma)
- Bowel gas pattern shows displacement; rarely a mass effect on the ipsilateral psoas shadow
- Chest X-ray: look for pulmonary metastases ("cannon ball" lesions)
Ultrasound (First-line modality)
- Intrarenal origin confirmed - normal renal tissue seen displaced/compressed around the mass ("claw sign")
- Large, heterogeneous, echogenic or mixed echogenicity mass
- Assessment of renal vein and IVC tumor thrombus (Doppler critical)
- Can identify bilateral tumors and contralateral kidney
- Cystic components, hemorrhage, or necrosis seen as hypoechoic areas
- Nephrogenic rests appear as peripheral hypoechoic rim lesions
CT (Computed Tomography) - Primary staging modality
- Pre-contrast: heterogeneous, well-circumscribed intrarenal mass, usually hypodense to normal renal parenchyma
- Post-contrast (nephrographic phase): heterogeneous enhancement; the "claw sign" of normal enhancing renal parenchyma curving around the tumor margin is characteristic
- Confirms renal origin of mass
- Evaluates: bilateral tumors, lymph nodes, IVC/renal vein thrombus, liver metastases
- Calcifications in ~10% (peripheral/scattered, unlike neuroblastoma's coarse stippled calcification)
- Tumor does NOT cross midline (unlike neuroblastoma which encases/displaces great vessels across midline)
- Aorta displaced posteriorly by the mass (contrast with neuroblastoma which displaces aorta anteriorly)
- Pulmonary metastases: CT chest detects small lesions not seen on CXR; COG vs SIOP differ on chest CT significance
- "Rule of 10's": ~10% unfavorable histology, 10% bilateral, 10% vascular invasion, 10% calcifications, 10% lung metastases at presentation
MRI - Preferred for bilateral tumors and vascular assessment
- T1W: low signal intensity mass with variable heterogeneity
- T2W: variable to high signal intensity; high signal nephrogenic rests (if cystic) or hypointense sclerotic NRs
- "Claw sign" of normal renal tissue well shown on T2W
- DWI (Diffusion-weighted imaging): restricted diffusion in non-cystic Wilms components; ADC substantially higher than neuroblastoma - useful differentiator
- Gadolinium-enhanced MRI: heterogeneous enhancement pattern
- Superior to CT for: bilateral tumors, nephroblastomatosis, IVC extension, no ionizing radiation
- MRA (MR angiography): useful for surgical resectability planning
Wilms Tumor Staging (COG/NWTS System)
| Stage | Description | Management |
|---|
| I | Tumor confined to kidney, capsule intact, complete excision | Surgery + VCR + AMD |
| II | Local spread beyond kidney (including renal vein involvement); tumor spillage confined to flank; complete resection still possible | Surgery + VCR + AMD, no RT |
| III | Residual non-hematogenous disease after surgery; lymph node involvement; peritoneal contamination; positive margins | Surgery + VCR + AMD + DOX + abdominal RT |
| IV | Hematogenous metastases (lungs, liver, bone, brain) or extra-abdominal lymph nodes | Surgery + VCR + AMD + DOX + whole-lung/liver RT if needed |
| V | Bilateral renal involvement at diagnosis | Bilateral biopsies → chemotherapy → nephron-sparing surgery |
VCR = vincristine, AMD = dactinomycin, DOX = doxorubicin, RT = radiation therapy
(COG uses upfront surgery; SIOP uses pre-operative chemotherapy then post-surgical staging)
Associated Syndromes with Wilms Tumor
| Syndrome | Features | Gene/Locus | Risk of Wilms |
|---|
| WAGR syndrome | Wilms tumor + Aniridia + Genitourinary abnormalities + mental Retardation | Deletion 11p13 (WT1 + PAX6) | ~30-50% |
| Denys-Drash syndrome | Wilms + diffuse mesangial sclerosis (nephropathy) + pseudohermaphroditism | WT1 mutation | ~90% |
| Beckwith-Wiedemann syndrome | Macroglossia + omphalocele + organomegaly + hemihypertrophy + hypoglycemia | 11p15 (IGF2/H19) | ~4-10% |
| Isolated hemihypertrophy | Asymmetric body growth | 11p15 | Moderate risk |
| Frasier syndrome | Nephrotic syndrome + gonadal dysgenesis | WT1 splice site | Low |
| Trisomy 18 | Edwards syndrome features | Chromosome 18 | Associated |
| Isolated aniridia | Absent/rudimentary iris | PAX6 (11p13) | ~30% |
Screening recommendation: abdominal ultrasound every 3 months until age 7-8 for high-risk syndromes.
PART II: NEUROBLASTOMA
Epidemiology & Clinical Features
- Most common extracranial solid tumor of childhood; ~8-10% of all pediatric cancers
- Median age at diagnosis: 18 months; 90% diagnosed before age 5
- Arises from neural crest cells of the adrenal medulla (most common site, ~35%) or anywhere along the sympathetic chain (paravertebral, paraspinal, mediastinum, neck, pelvis)
- Often presents as an ill child with abdominal distension, weight loss, fever, hypertension, bone pain, "raccoon eyes" (periorbital ecchymosis from orbital metastases), "blueberry muffin" skin nodules (neonatal)
- Elevated urinary catecholamine metabolites (VMA, HVA) in >90% of cases - key diagnostic marker
Pathophysiology
- Differentiates along sympathoadrenal lineage
- Spectrum: neuroblastoma (undifferentiated) → ganglioneuroblastoma (intermediate) → ganglioneuroma (benign, well-differentiated)
- Key prognostic molecular markers: MYCN amplification (poor prognosis), ALK mutation, chromosomal abnormalities (1p deletion, 11q deletion, 17q gain)
- Segmental chromosomal abnormalities vs numerical chromosomal abnormalities (better prognosis)
Imaging of Neuroblastoma
Plain Radiography
- Calcifications visible in 50-60% on plain film (stippled, granular, "popcorn" pattern) - much more common than Wilms
- Soft-tissue mass; may show rib erosion or vertebral body involvement
- Chest X-ray may show paraspinal widening (posterior mediastinal mass) or pleural effusion
Ultrasound
- Suprarenal heterogeneous mass with coarse echogenic foci (calcifications)
- Displaces the kidney inferiorly and laterally (vs Wilms which is intrarenal)
- Doppler: assesses vascular encasement; the aorta may be elevated/lifted
- Liver: assess for metastatic involvement (diffuse infiltration or focal hypoechoic masses)
CT - Key imaging modality
- Large retroperitoneal suprarenal mass, often crossing the midline
- Calcifications in 80-90% on CT (coarse, stippled, amorphous)
- Aorta encased/displaced ANTERIORLY - classic distinguishing feature from Wilms (which pushes aorta posteriorly)
- Heterogeneous enhancement with necrotic areas
- Engulfs and encases great vessels (aorta, IVC, celiac axis, SMA) without occluding them - "vascular encasement sign"
- Lymphadenopathy: retroperitoneal, paraaortic nodes
- Intraspinal extension via neural foramina ("dumbbell tumor") in 10% abdominal, 28% thoracic
- Liver metastases: focal hypoenhancing masses or diffuse infiltration
- Bone cortex involvement, marrow infiltration
MRI - Preferred for staging and intraspinal extension
- T1W: low to intermediate signal
- T2W: high signal intensity; excellent contrast between tumor and surrounding tissues; preferred for intraspinal dumbbell extension
- DWI: restricted diffusion with low ADC values (substantially lower than Wilms - key differentiator)
- MIBG scintigraphy (meta-iodobenzylguanidine): functional imaging - highest specificity (85%) for staging bone/marrow disease; positive in ~90% of tumors
- Combined MRI + MIBG: sensitivity 99%, specificity 95%
- MRI preferred over CT for: intraspinal extension, liver metastases (T2W hyperintense), bone marrow infiltration, radiation avoidance
- ¹²³I-MIBG scan: whole-body staging for bone, bone marrow, soft tissue disease
Axial T2W MRI: Left adrenal neuroblastoma filling the retroperitoneum and displacing the aorta anteriorly (arrow) - Grainger & Allison's Diagnostic Radiology
Neuroblastoma Staging (INRG / INSS)
INSS (International Neuroblastoma Staging System) - post-surgical
| Stage | Description |
|---|
| 1 | Localized, complete gross resection, ipsilateral nodes negative |
| 2A | Localized, incomplete resection, ipsilateral nodes negative |
| 2B | Localized ± complete resection, ipsilateral nodes positive |
| 3 | Unresectable, crosses midline ± regional node involvement; OR contralateral nodes positive |
| 4 | Distant metastases (bone, bone marrow, liver, lymph nodes except 4S) |
| 4S | Localized primary + metastases to skin, liver, and/or bone marrow (< 1 year old); favorable spontaneous regression |
INRG (International Neuroblastoma Risk Group) - pre-surgical, image-defined
Uses Image Defined Risk Factors (IDRFs) to predict surgical resectability:
- Vascular encasement (aorta, IVC, renal vessels, celiac axis, SMA)
- Intraspinal extension (> 1/3 spinal canal)
- Involvement of adjacent organs (liver, diaphragm, kidney)
- Infiltration of structures at neck/thoracic inlet
Associated Syndromes with Neuroblastoma
| Syndrome | Association |
|---|
| Beckwith-Wiedemann | Rare association |
| NF-1 (Neurofibromatosis type 1) | Increased risk |
| Hirschsprung disease | Some association (rare) |
| Costello syndrome | HRAS mutation, predisposed to neuroblastoma |
| ALK germline mutation | Familial neuroblastoma |
| Gorlin syndrome (PHACES) | Vascular + neuroblastoma association |
| Opsoclonus-myoclonus syndrome | Paraneoplastic - associated with localized/favorable neuroblastoma |
PART III: HEAD-TO-HEAD COMPARISON - WILMS vs NEUROBLASTOMA
| Feature | Wilms Tumor | Neuroblastoma |
|---|
| Age | 2-5 years (peak 3rd year) | < 2 years (median 18 months) |
| Origin | Intrarenal (metanephric blastema) | Suprarenal/extrarenal (adrenal medulla, sympathetic chain) |
| Clinical presentation | Asymptomatic abdominal mass; well child | Ill child; fever, weight loss, bone pain, raccoon eyes |
| Calcification (plain film) | Uncommon (~10%) | Common (50-60%) |
| Calcification (CT) | ~10%, peripheral rim | ~80-90%, stippled/coarse/amorphous |
| Kidney | Kidney is the mass; intrarenal; shows "claw sign" | Kidney displaced/compressed but separate; extrinsic mass |
| Aorta displacement | Pushed posteriorly | Lifted/displaced anteriorly; often encased |
| Midline crossing | Rarely crosses midline | Frequently crosses midline; encases vessels |
| IVC involvement | IVC/renal vein tumor thrombus (10%) | Encasement (extrinsic) without thrombosis |
| Metastases | Lungs > liver | Bone, bone marrow, liver, skin (4S) |
| Liver mets pattern | Focal nodular masses | Diffuse infiltration OR focal hypoenhancing |
| DWI/ADC | Higher ADC (less restricted) | Lower ADC (more restricted) |
| MRI T2W | Variable-high signal; claw sign | Very high signal; engulfs vessels |
| Nuclear medicine | No standard nuclear medicine role | MIBG scan (¹²³I) - high specificity |
| Urinary catecholamines | Normal | Elevated VMA, HVA (>90%) |
| Intraspinal extension | Rare | 10% abdominal (dumbbell tumor) |
| Bilateral disease | 5% bilateral | Rare |
| Prognosis | Generally excellent (>90% cure FH Stage I-II) | Variable; 4S has excellent prognosis; Stage 4 poor |
PART IV: OTHER PEDIATRIC RENAL MASSES
1. Congenital Mesoblastic Nephroma (CMN)
- Most common renal tumor in neonates (< 3 months); mean age at presentation 3.5 months
- Benign spindle-cell tumor; two subtypes: classic (fibrous) and cellular (more aggressive)
- Imaging: large, solid, intrarenal mass replacing most of the kidney; hypoechoic on US; heterogeneous on CT/MRI; no calcifications; no pseudocapsule
- Treated with nephrectomy alone (classic type); cellular type may recur - close follow-up
2. Clear Cell Sarcoma of Kidney (CCSK)
- "Bone-metastasizing renal tumor of childhood" - propensity for bone metastases (unlike Wilms)
- Peak age 1-4 years; males predominate
- Pathology: monomorphous spindle/ovoid cells with arborizing vasculature; mucoid extracellular matrix
- Imaging: large, homogeneous, intrarenal mass; CT shows hypodense well-circumscribed mass; may have cysts and calcifications; MRI preferred - intermediate T1, heterogeneous T2
- No specific imaging features to distinguish from Wilms preoperatively
- Treatment includes doxorubicin (unlike favorable-histology Wilms Stage I-II)
3. Rhabdoid Tumor of Kidney (RTK)
- Most aggressive renal tumor of childhood; very young infants (< 2 years, peak 11 months)
- Associated with brain tumors (primitive neuroectodermal tumors/AT/RT) - SMARCB1/INI1 mutation
- Pathology: large vesicular cells with prominent nucleoli and cytoplasmic inclusions
- Imaging: infiltrative large intrarenal mass; subcapsular fluid collection is characteristic; calcifications (~25%); often metastatic at diagnosis (bone, brain, lungs)
- CT: heterogeneous mass; subcapsular crescent may be seen
- Brain MRI mandatory to exclude synchronous primitive neuroectodermal tumor of brain
4. Multilocular Cystic Nephroma (MLCN)
- Benign cystic renal tumor; bimodal age distribution (boys < 2 years; women 30-50 years)
- Imaging: well-circumscribed multi-septated cystic mass; septa may herniate into renal pelvis (CT/MRI "herniation sign" into collecting system)
- CT: multiple non-communicating cysts separated by enhancing septa
- Shares features with multicystic dysplastic kidney (MCDK) and cystic Wilms; cystic Wilms occurs in children ~2-4 years
5. Renal Cell Carcinoma (RCC) in Children
- Rare in children (<5% of pediatric renal tumors); more common in adolescents
- Often associated with: Xp11.2 translocation (TFE3 gene), VHL disease, tuberous sclerosis, hereditary papillary RCC
- Imaging: similar to adult RCC - heterogeneous solid renal mass, CT shows arterial phase enhancement; calcifications more common than in adults with childhood RCC
- Xp11.2 translocation RCC: calcifications, lymph node metastases, may have papillary architecture
6. Renal Lymphoma
- Rare primary; secondary involvement more common in NHL
- Bilateral diffuse infiltration or multiple hypoechoic/hypodense masses
- CT: "multiple soft tissue masses" pattern; minimal enhancement
PART V: IMAGING MODALITY SUMMARY FOR PEDIATRIC RENAL MASSES
| Modality | Role | Key Points |
|---|
| Ultrasound | First-line; establishes renal vs extra-renal origin | Claw sign; Doppler for IVC thrombus; no radiation |
| CT abdomen/pelvis with contrast | Primary staging; lymph nodes, vascular extension, bilateral tumors | Heterogeneous enhancement; midline crossing; calcifications; aortic displacement |
| CT chest | Pulmonary metastases | Superior to CXR; COG/SIOP differ on significance for small CT-only lesions |
| MRI | Preferred for bilateral Wilms, nephroblastomatosis, intraspinal neuroblastoma, serial surveillance | No radiation; superior soft tissue; DWI for characterization |
| MIBG scintigraphy | Neuroblastoma staging (bone, marrow) | Highest specificity (85%); combined with MRI: sensitivity 99%, specificity 95% |
| Bone scan | CCSK (bone mets), neuroblastoma (if MIBG negative) | Tc-99m MDP |
| PET-CT | Limited role in Wilms (reserved for relapse); some role in MIBG-negative neuroblastoma | Increased radiation; ADC on DWI is preferred for Wilms |
| DWI/ADC | Differentiate Wilms from neuroblastoma | ADC higher in Wilms; lower in neuroblastoma |
Quick Reference: Key Distinguishing Imaging Clues
Clue: Intrarenal mass with claw sign + no calcification + no midline crossing → Wilms tumor
Clue: Suprarenal mass, coarse calcifications, aorta anteriorly displaced, crosses midline, ill child → Neuroblastoma
Clue: Neonate with intrarenal mass, no pseudocapsule → Mesoblastic nephroma
Clue: Mass + subcapsular fluid crescent + brain tumor → Rhabdoid tumor
Clue: Multi-septated cystic mass herniating into renal pelvis → Multilocular cystic nephroma
Clue: Young child, bone metastases, intrarenal mass → Clear cell sarcoma
Sources: Smith & Tanagho's General Urology 19e; Campbell-Walsh-Wein Urology 3-Vol Set; Grainger & Allison's Diagnostic Radiology; Mulholland & Greenfield's Surgery 7e; PMC4446071 - Neuroblastoma and nephroblastoma: a radiological review (2015); NCI PDQ Wilms Tumor Treatment Guidelines 2024